 | Up a level |
Jawharl, M., Naumann, N., Schwaab, J., Dietz, C., Casper, J., Dang, T. A., Dietze, L., Doehner, K., Haenel, A., Lathan, B., Link, H., Lotfti, S., Mielkel, S., Luber, V., Maywald, O., Mueller, L., Platzbecker, U., Pruemmer, O., Thomssen, H., Toepelt, K., Schmitt, K., Baurmann, H., Vielert, T., Hofmann, W. K., Haferlach, C., Cross, N. C., Fabarius, A., Reiter, A. and Metzgeroth, G. (2016). CLINICAL CHARACTERISTICS AND LONG-TERM OUTCOME ON IMATINIB IN PATIENTS WITH MYELOID/LYMPHOID NEOPLASMS AND ASSOCIATED PDGFRB FUSION GENES IN CHRONIC OR BLAST PHASE. Haematologica, 101. S. 264 - 266. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
Koenigsmann, M., Casper, J., Kahl, C., Basara, N., Sayer, H. G., Behre, G., Theurich, S., Christopeit, M., Mohren, M., Reichle, A., Metzner, B., Ganser, A., Stadler, M., Uharek, L., Balleisen, L., Hinke, A., Hinke, R. and Niederwieser, D. (2014). Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial. Bone Marrow Transplant., 49 (3). S. 410 - 416. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365
Nagler, A., Labopin, M., Shimoni, A., Beelen, D., Kyrcz-Krzemien, S., Schufer-Eckart, K., Volin, L., Hallek, M., Griskevicius, L., Blau, I. Wolfgang, Casper, J., Ciceri, F. and Mohty, M. (2014). TREOSULFAN BASED CONDITIONING PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION (HSCT) FOR ACUTE MYELOGENOUS LEUKEMIA (AML): A RETROSPECTIVE ANALYSIS FROM THE ALWP OF THE EBMT. Bone Marrow Transplant., 49. S. S7 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365
Roeth, A., Raiser, C., Panse, J., Steinbach, Cicalo F., Sockel, K., Haferlach, T., Huebel, K., Blau, I. W., Casper, J., Platzbecker, U., Ganser, A., Hoechsmann, B. and Schrezenmeier, H. (2020). Changes in the burden of disease in treated and untreated patients in the German cohort of the International Registry of Paroxysmal Nocturnal Hemoglobinuria (PNH) - a 2020 Update. Oncol. Res. Treat., 43 (SUPPL 4). S. 174 - 175. BASEL: KARGER. ISSN 2296-5262